Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $35.48B | 1.90% | 1.10% | 3.08% | 6.60% | 0.85 | 2.39 | 86.20% | 1.40% | 3.26% | ||
| NVO | NOVO NORDISK A S | $244.88B | 67.00% | 21.30% | 47.46% | 56.40% | 2.02 | 0.78 | 82.00% | 32.90% | 41.80% | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $52.56B | 26.10% | 1.00% | 3.95% | 2.60% | 19.74 | 2.54 | 83.90% | 1.40% | 4.06% | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.11B | 7.50% | 5.60% | 8.26% | 14.10% | 0.33 | 3.85 | 87.50% | 6.00% | 8.13% | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $469.52M | 42.70% | 16.10% | 25.35% | 37.20% | 1.03 | 8.62 | 80.70% | 41.90% | 73.31% | ||
| CORT | CORCEPT THERAPEUTICS INC | $3.68B | 15.90% | 12.60% | 9.84% | 11.20% | 0.30 | 3.14 | 98.20% | 14.10% | 8.65% | ||
| VCEL | VERICEL CORP | $1.88B | 4.30% | 3.00% | 3.40% | 3.50% | 0.41 | 4.87 | 73.80% | 5.10% | 5.35% | ||
| ARGX | ARGENX SE | $48.88B | 24.70% | 21.40% | 10.88% | 20.20% | 0.18 | 5.60 | -19,733.10% | 78,552.00% | 40,946.87% | ||
| KRYS | KRYSTAL BIOTECH INC | $7.10B | 19.40% | 17.60% | 16.27% | 26.80% | 0.09 | 10.14 | 94.30% | 53.30% | 50.10% | ||
| TECH | BIO-TECHNE CORP | $9.82B | 3.90% | 3.00% | 4.82% | 8.70% | 0.29 | 4.22 | 65.40% | 6.40% | 9.43% | ||
| GMAB | GENMAB A | $20.42B | 27.40% | 22.20% | 30.81% | 79.80% | 0.22 | 6.03 | 94.30% | 41.30% | 54.29% | ||
| ABEO | ABEONA THERAPEUTICS INC | $282.88M | 78.40% | 48.00% | 41.45% | 86.10% | 0.35 | 9.74 | -22.00% | 20,587.50% | 21,650.75% | ||
| ADMA | ADMA BIOLOGICS INC | $4.29B | 54.00% | 39.40% | 32.05% | 35.70% | 0.32 | 7.13 | 54.70% | 42.90% | 33.60% | ||
| XOMA | XOMA ROYALTY CORP | $329.64M | 20.30% | 7.20% | 10.39% | 12.10% | 1.77 | 3.91 | 100.00% | 35.20% | 51.78% | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.02B | 21.80% | 14.90% | 18.63% | 18.80% | 0.44 | 5.76 | 88.90% | 29.30% | 31.63% | ||
| VCYT | VERACYTE INC | $3.45B | 2.50% | 2.30% | 2.39% | 15.10% | 0.09 | 6.23 | 68.50% | 6.10% | 6.26% | ||
| LGND | LIGAND PHARMACEUTICALS INC | $3.78B | 5.70% | 4.50% | 4.62% | 9.50% | 0.55 | 24.69 | 94.30% | 19.30% | 26.59% | ||
| CRMD | CORMEDIX INC | $960.44M | 81.80% | 51.10% | 17.50% | 93.70% | 1.01 | 1.94 | 92.60% | 75.80% | 50.40% | ||
| MNKD | MANNKIND CORP | $1.73B | -49.30% | 6.80% | 16.19% | 11.30% | -12.10 | 3.29 | 75.20% | 9.30% | 19.89% | ||
| NAGE | NIAGEN BIOSCIENCE INC | $514.75M | 34.60% | 24.10% | 28.18% | 203.70% | 0.39 | 4.12 | 63.90% | 16.40% | 17.04% | ||
| RPRX | ROYALTY PHARMA PLC | $22.89B | 7.80% | 4.20% | 5.55% | 4.30% | 1.01 | 3.48 | 100.00% | 32.60% | 44.44% | ||
| EXEL | EXELIXIS INC | $11.37B | 31.60% | 24.00% | 35.65% | 37.50% | 0.31 | 3.75 | 96.60% | 29.60% | 38.16% | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $113.87B | 21.80% | 15.60% | 21.88% | 30.10% | 0.44 | 2.36 | 86.30% | 31.30% | 38.06% | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $143.95M | 11.30% | 7.00% | 12.37% | 18.00% | 0.56 | 3.03 | 57.50% | 8.70% | 12.06% | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.31B | 8.80% | 7.10% | 10.12% | 12.20% | 0.26 | 4.83 | 81.30% | 16.80% | 22.30% | ||
| APLS | APELLIS PHARMACEUTICALS INC | $3.15B | 18.90% | 5.00% | 11.77% | 12.30% | 1.64 | 3.54 | 88.80% | 4.40% | 9.02% | ||
| HALO | HALOZYME THERAPEUTICS INC | $8.37B | 141.60% | 27.90% | 55.18% | 32.60% | 3.41 | 1.59 | 84.50% | 47.90% | 61.45% | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.12B | 24.90% | 17.00% | 24.96% | 55.80% | 0.45 | 3.76 | 77.70% | 22.50% | 29.76% | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.80B | 26.40% | 23.00% | 30.97% | 370.30% | 0.14 | 6.62 | 85.70% | 37.60% | 49.43% | ||
| REGN | REGENERON PHARMACEUTICALS INC | $80.22B | 15.30% | 11.90% | 14.51% | 15.50% | 0.30 | 4.06 | 85.40% | 32.10% | 36.41% | ||
| MDXG | MIMEDX GROUP INC | $937.49M | 19.20% | 14.30% | 20.39% | 49.90% | 0.34 | 4.41 | 82.00% | 10.40% | 13.54% | ||
| INVA | INNOVIVA INC | $1.50B | 16.60% | 9.60% | 12.65% | 18.40% | 0.42 | 14.12 | 81.50% | 32.80% | 44.95% | ||
| UTHR | UNITED THERAPEUTICS CORP | $21.08B | 18.80% | 16.80% | 24.85% | 31.70% | 0.12 | 6.40 | 88.60% | 40.70% | 54.04% | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $4.42B | 32.30% | 21.40% | 28.09% | 51.70% | 0.45 | 3.02 | 91.90% | 24.90% | 26.14% | ||
| INCY | INCYTE CORP | $19.98B | 29.80% | 20.40% | 31.86% | 76.00% | 0.36 | 3.20 | 92.90% | 24.70% | 33.05% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.